Theratechnologies Inc. (TH) — Capital Reinvestment Ratio
Latest as of May 2025:
3.80x
Theratechnologies Inc. (TH) has a Capital Reinvestment Ratio of 3.80x as of May 2025, meaning it reinvests 4% of its operating cash flow (CA$2.66 Million) in capital expenditures (CA$10.11 Million). See TH free cash flow generation to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
3.80x
Capex / Operating Cash Flow
Operating Cash Flow
CA$2.66 Million
CAD
Capital Expenditures
CA$10.11 Million
CAD
Data as of
May 2025
Most recent filing
Theratechnologies Inc. Capital Reinvestment Ratio (2009–2024)
This chart tracks Theratechnologies Inc.'s Capital Reinvestment Ratio across 6 annual periods.
Annual Capital Reinvestment Ratio for Theratechnologies Inc. (2009–2024)
Year-by-year Capital Reinvestment Ratio for Theratechnologies Inc. from 2009 to 2024. For live market cap and broader valuation context, see TH company net worth.
| Year | Reinvestment Ratio | Operating CF (CAD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 0.63x | CA$2.38 Million | CA$1.50 Million | ▲ +1529.4% |
| 2017 | 0.04x | CA$1.91 Million | CA$73.82K | ▼ -93.5% |
| 2016 | 0.59x | CA$2.00 Million | CA$1.19 Million | ▲ +10058.0% |
| 2015 | 0.01x | CA$5.30 Million | CA$31.00K | ▼ -95.9% |
| 2010 | 0.14x | CA$2.84 Million | CA$407.05K | ▲ +98.9% |
| 2009 | 0.07x | CA$5.35 Million | CA$384.80K | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow